With an improved median survival of 6.2 years, lung transplantation has become an increasingly acceptable treatment option for end-stage lung disease. Besides survival benefit, improvement of quality of life is achieved in the vast majority of patients. Many developments have taken place in the field of lung transplantation over the past decade. Broadened indication criteria and bridging techniques for patients awaiting lung transplantation have led to increased waiting lists and changes in allocation schemes worldwide. Moreover, the use of previously unacceptable donor lungs for lung transplantation has increased, with donations from donors after cardiac death, donors with increasing age and donors with positive smoking status extending the donor pool substantially. Use of ex vivo lung perfusion further increased the number of lungs suitable for lung transplantation. Nonetheless, the use of these previously unacceptable lungs did not have detrimental effects on survival and long-term graft outcomes, and has decreased waiting list mortality. To further improve long-term outcomes, strategies have been proposed to modify chronic lung allograft dysfunction progression and minimise toxic immunosuppressive effects. This review summarises the developments in clinical lung transplantation over the past decade.

dx.doi.org/10.1183/16000617.0132-2019, hdl.handle.net/1765/129211
European respiratory review : an official journal of the European Respiratory Society
Department of Pulmonology

van der Mark, S.C. (Sophie C.), Hoek, R.A.S, & Hellemons, M.E. (Merel E.). (2020). Developments in lung transplantation over the past decade. European respiratory review : an official journal of the European Respiratory Society (Vol. 29). doi:10.1183/16000617.0132-2019